Neovasc (TSE:NVCN) Stock Price Down 0.5%

Shares of Neovasc Inc. (TSE:NVCNGet Rating) traded down 0.5% on Friday . The stock traded as low as C$40.15 and last traded at C$40.15. 1,156 shares changed hands during trading, a decline of 55% from the average session volume of 2,566 shares. The stock had previously closed at C$40.35.

Neovasc Trading Down 0.5 %

The company has a current ratio of 8.44, a quick ratio of 8.04 and a debt-to-equity ratio of 44.86. The firm has a market capitalization of C$110.81 million, a P/E ratio of -2.33 and a beta of 2.01. The firm has a 50-day moving average of C$37.07 and a two-hundred day moving average of C$20.30.

Neovasc Company Profile

(Get Rating)

Neovasc Inc, a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina.

See Also

Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with's FREE daily email newsletter.